Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26F1009
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $99,024
Award facts
- Contract value 100% obligated
- $99,024.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $99,024.18 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pens on November 7, 2025, with an ultimate completion date of November 10, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania.
Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis, asthma, and other allergic conditions, making this delivery order part of DLA's broader pharmaceutical supply mission supporting military and federal healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen provides comprehensive medical commodities including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains to support Defense Health Agency and other government healthcare customers worldwide. The firm fixed-price delivery order structure and rapid completion timeline reflect the standardized procurement approach under DLA's pharmaceutical prime vendor program.
Quick answers
Who was awarded contract SPE2DR26F1009?
SPE2DR26F1009 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DR26F1009 worth?
The government has obligated $99,024 on SPE2DR26F1009.
Is contract SPE2DR26F1009 an order under another contract?
Yes. SPE2DR26F1009 is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26F1009 competed?
The extent of competition for SPE2DR26F1009 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award